HomeCompareITI vs CL

ITI vs CL: Dividend Comparison 2026

ITI yields 27.82% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ITI wins by $75.8K in total portfolio value
10 years
ITI
ITI
● Live price
27.82%
Share price
$7.19
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$116.6K
Annual income
$14,445.19
Full ITI calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — ITI vs CL

📍 ITI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodITICL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ITI + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ITI pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ITI
Annual income on $10K today (after 15% tax)
$2,364.39/yr
After 10yr DRIP, annual income (after tax)
$12,278.41/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, ITI beats the other by $7,686.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ITI + CL for your $10,000?

ITI: 50%CL: 50%
100% CL50/50100% ITI
Portfolio after 10yr
$78.7K
Annual income
$9,923.58/yr
Blended yield
12.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

ITI
Analyst Ratings
6
Buy
3
Hold
Consensus: Buy
Price Target
$8.33
+15.9% upside vs current
Range: $6.00 — $11.00
Altman Z
3.7
Piotroski
5/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ITI buys
0
CL buys
0
No recent congressional trades found for ITI or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricITICL
Forward yield27.82%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$116.6K$40.8K
Annual income after 10y$14,445.19$5,401.96
Total dividends collected$77.2K$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold
Analyst price target$8.33$92.45

Year-by-year: ITI vs CL ($10,000, DRIP)

YearITI PortfolioITI Income/yrCL PortfolioCL Income/yrGap
1← crossover$13,482$2,781.64$11,012$312.01+$2.5KITI
2$17,930$3,504.77$12,196$412.95+$5.7KITI
3$23,542$4,356.29$13,599$549.66+$9.9KITI
4$30,535$5,345.45$15,288$736.64+$15.2KITI
5$39,152$6,479.81$17,353$995.28+$21.8KITI
6$49,658$7,764.93$19,926$1,357.80+$29.7KITI
7$62,338$9,204.18$23,194$1,873.82+$39.1KITI
8$77,500$10,798.59$27,439$2,621.52+$50.1KITI
9$95,472$12,546.82$33,088$3,727.38+$62.4KITI
10$116,600$14,445.19$40,806$5,401.96+$75.8KITI

ITI vs CL: Complete Analysis 2026

ITIStock

Iteris, Inc. provides intelligent transportation systems technology solutions in North America, Europe, South America, and Asia. The company offers smart mobility infrastructure solutions include traveler information systems, transportation performance measurement software, traffic analytics software, transportation operations software, transportation-related data sets, advanced sensing devices, managed services, traffic engineering services, and mobility consulting services. Its products include ClearGuide, ClearRoute, Commercial Vehicle Operations, BlueArgus, TrafficCarma, Vantage Apex, Vantage Fusion, Vantage Next, VantagePegasus, VantageRadius, Vantage Vector, Velocity, SmartCycle, SmartCycle Bike Indicator, SmartSpan, VersiCam, PedTrax, and P-Series products. The company also sells original equipment manufacturer products for the traffic intersection markets, such as traffic signal controllers and traffic signal equipment cabinets. In addition, it offers traffic management centers design, staffing, and operations services; traffic engineering and mobility consulting services include planning, design, development, and implementation of software and hardware-based ITS systems that integrate sensors, video surveillance, computers, and advanced communications equipment; distributes real-time information about traffic conditions; and surface transportation infrastructure systems implementation, and operation and management. Further, the company provides travel demand forecasting and systems engineering, and identify mitigation measures to reduce traffic congestion; ClearMobility platform; and ClearMobility Cloud that enables mobility data management engine, application programming interface framework, and microservices ecosystem. It serves public transportation agencies, municipalities, commercial entities, government agencies, and other transportation infrastructure providers. The company was founded in 1969 and is headquartered in Austin, Texas.

Full ITI Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this ITI vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ITI vs SCHDITI vs JEPIITI vs OITI vs KOITI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.